Published in J Clin Microbiol on July 14, 2010
Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model. Antimicrob Agents Chemother (2012) 1.09
Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals. PLoS One (2013) 1.05
Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2012) 1.03
Nosocomial methicillin resistant Staphylococcus aureus pneumonia - epidemiology and trends based on data of a network of 586 German ICUs (2005-2009). Eur J Med Res (2010) 0.98
Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital. BMC Infect Dis (2011) 0.96
Epidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals. Infect Control Hosp Epidemiol (2014) 0.82
Small Molecule Inhibitors Limit Endothelial Cell Invasion by Staphylococcus aureus. Curr Pharm Biotechnol (2014) 0.78
Control of Methicillin-Resistant Staphylococcus aureus Pneumonia Utilizing TLR2 Agonist Pam3CSK4. PLoS One (2016) 0.78
Rapid diagnostic test and use of antibiotic against methicillin-resistant Staphylococcus aureus in adult intensive care unit. Eur J Clin Microbiol Infect Dis (2016) 0.76
Differences in hospital- and ventilator-associated pneumonia due to Staphylococcus aureus (methicillin-susceptible and methicillin-resistant) between Europe and Latin America: a comparison of the EUVAP and LATINVAP study cohorts. Med Intensiva (2012) 0.75
Financial impact of health care-associated infections: When money talks. Can J Infect Dis Med Microbiol (2014) 0.75
Comparison of methicillin-resistant Staphylococcus aureus community-acquired and healthcare-associated pneumonia. Yonsei Med J (2014) 0.75
Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA (2007) 26.98
Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis (1999) 19.52
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax (2003) 9.54
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis (2008) 8.58
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med (2006) 7.56
Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science (2007) 7.06
Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest (2005) 5.91
Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest (2008) 2.83
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J Clin Microbiol (2006) 2.74
Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis (2006) 2.52
Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother (2007) 2.49
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med (2009) 1.82
Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med (2009) 1.76
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med (2006) 8.20
Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13
Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2006) 5.86
Building a virtual cancer research organization. J Natl Cancer Inst Monogr (2005) 3.60
CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr (2006) 3.39
Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin Infect Dis (2011) 3.08
Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol (2005) 3.02
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis (2013) 3.00
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis (2003) 2.84
Population-wide benefits of routine vaccination of children against influenza. Vaccine (2005) 2.68
Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia (2005) 2.60
Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database. Crit Care Med (2006) 2.51
Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol (2007) 2.44
Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis (2009) 2.41
Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med (2003) 2.39
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. Diabetes Care (2003) 2.29
Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr (2007) 2.17
Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med (2011) 2.16
Therapy switching in patients receiving long-acting opioids. Ann Pharmacother (2004) 2.14
Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model. Value Health (2004) 2.05
Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol (2006) 1.96
Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med (2009) 1.94
Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database. Crit Care Med (2009) 1.93
Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain (2004) 1.92
Epidemiology of Staphylococcus aureus colonization in nursing home residents. Clin Infect Dis (2008) 1.72
Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer (2007) 1.71
Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. J Natl Cancer Inst (2012) 1.70
Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Clin Trials (2009) 1.65
The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy. Breast J (2012) 1.64
Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer (2006) 1.61
Is sepsis accurately coded on hospital bills? Value Health (2002) 1.60
Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Med Assoc (2008) 1.60
Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother (2011) 1.58
Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. Am J Manag Care (2009) 1.52
Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Invest (2002) 1.49
Effect of race on the frequency of postoperative atrial fibrillation following coronary artery bypass grafting. Am J Cardiol (2011) 1.48
The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Oncology (2004) 1.47
Routine surveillance care after cancer treatment with curative intent. Med Care (2005) 1.45
Economic burden of endometriosis. Fertil Steril (2006) 1.43
Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol (2008) 1.41
Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq. Vaccine (2009) 1.40
Is previous exposure to hepatitis B a risk factor for pancreatic cancer or hepatocellular carcinoma? J Clin Gastroenterol (2014) 1.40
Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr (2005) 1.39
Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) (2006) 1.38
Opioid use and health care charges at the end of life in patients with metastatic cancer. Manag Care Interface (2004) 1.38
Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective. J Med Econ (2008) 1.35
Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis (2013) 1.33
Human and swine hosts share vancomycin-resistant Enterococcus faecium CC17 and CC5 and Enterococcus faecalis CC2 clonal clusters harboring Tn1546 on indistinguishable plasmids. J Clin Microbiol (2011) 1.31
Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality. BMC Cancer (2011) 1.30
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis (2010) 1.29
Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol (2006) 1.28
Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst (2012) 1.27
Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy (2010) 1.25
Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin (2008) 1.23
Economic costs of nonmedical use of prescription opioids. Clin J Pain (2011) 1.22
Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology. Clin Infect Dis (2003) 1.19
Risk for renal cell carcinoma in chronic hepatitis C infection. Cancer Epidemiol Biomarkers Prev (2010) 1.17
Health-related quality of life burden of women with endometriosis: a literature review. Curr Med Res Opin (2006) 1.15
Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization? Ann Pharmacother (2006) 1.15
Enhancing adherence among older African American men enrolled in a longitudinal cancer screening trial. Gerontologist (2006) 1.12
Risk of venous thromboembolism among hospitalized medically ill patients. Am J Health Syst Pharm (2006) 1.12
The economic impact of uterine fibroids in the United States: a summary of published estimates. J Womens Health (Larchmt) (2005) 1.12
Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations. Infect Control Hosp Epidemiol (2007) 1.12
Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Support Care Cancer (2013) 1.10
Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study. Clin Ther (2009) 1.10
Risk-factor clustering and cardiovascular disease risk in hypertensive patients. Am J Hypertens (2007) 1.10
Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients. J Clin Microbiol (2011) 1.09
Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surg Infect (Larchmt) (2008) 1.09
Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. J Natl Cancer Inst (2013) 1.09
Resource utilization and costs before and after total joint arthroplasty. BMC Health Serv Res (2012) 1.06
Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study. BMC Pulm Med (2008) 1.05
The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer. Value Health (2002) 1.04
Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications? Med Care (2006) 1.04
Uterine fibroids: a review of health-related quality of life assessment. J Womens Health (Larchmt) (2006) 1.03
Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer (2006) 1.02
Use of oral antithrombotic agents among health maintenance organization members with atherosclerotic cardiovascular disease. Arch Intern Med (2002) 1.01
The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev (2004) 1.01
Clinical and economic consequences of bleeding following major orthopedic surgery. Thromb Res (2006) 1.01
Effectiveness of bisphosphonate therapy in a community setting. Bone (2008) 1.01
Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis. J Rheumatol (2011) 1.00
Dose intensification with infliximab in patients with rheumatoid arthritis. Ann Pharmacother (2005) 1.00
Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy. Am J Clin Oncol (2012) 0.99
Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Res Treat (2012) 0.99
Risk of further decline in renal function after the use of oral sodium phosphate or polyethylene glycol in patients with a preexisting glomerular filtration rate below 60 ml/min. Am J Gastroenterol (2008) 0.98
Treatment patterns and symptom control in patients with GERD: US community-based survey. Curr Med Res Opin (2009) 0.98
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy. BMC Health Serv Res (2011) 0.98
Inpatient surgical treatment patterns for patients with uterine fibroids in the United States, 1998-2002. J Natl Med Assoc (2005) 0.98
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation. Crit Care (2009) 0.97
Multistate outbreak of Burkholderia cenocepacia colonization and infection associated with the use of intrinsically contaminated alcohol-free mouthwash. Chest (2007) 0.97
Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol (2009) 0.96